Physician profile
Aric J Swancutt
NPI 1184252512
$2,949.09
in general payments reported to CMS, 2019-2025
14 companies · $754 in 2025
The $754 reported for 2025 was more than what 82% of Primary Podiatric Medicine providers received nationally (typical 2025 total: $232).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,924 · 2024: $271 · 2025: $754.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,640 · Food and Beverage: $1,310.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,639.57 |
| Food and Beverage | $1,309.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,910.39 | 2023-2025 | Prostep, Infinity, Prophecy |
| Linvatec Corporation | $445.46 | 2025 | Quantum, Biobrace 23mm, Colink Afx |
| Biotissue Holdings INC. | $156.01 | 2025 | |
| Abbott Laboratories | $142.04 | 2024 | Diamondback Peripheral |
| Smith+Nephew, INC. | $87.37 | 2023-2024 | Stravix, Grafix Pl, Grafix |
| Treace Medical Concepts, INC. | $37.16 | 2024-2025 | |
| Depuy Synthes Sales INC. | $33.69 | 2025 | Motoband |
| Paratek Pharmaceuticals, INC. | $30.82 | 2024 | Nuzyra |
| Cashflow Solutions, LLC | $20.21 | 2025 | Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White, Pcd-52 737a (US) White |
| Bioventus LLC | $19.96 | 2025 | Supartz Fx Sodium Hyaluronate |
| Organogenesis INC. | $18.83 | 2025 | Apligraf |
| Trice Medical, INC. | $17.70 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $16.33 | 2023 | Seglentis |
| Kerecis Limited | $13.12 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aric Swancutt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.